PHARMACY BOARD OF AUSTRALIA and HEGDE

Link copied
Case Copied 36 min read

JURISDICTION     :   STATE ADMINISTRATIVE TRIBUNAL

ACT: HEALTH PRACTITIONER REGULATION NATIONAL LAW (WA) ACT 2010 (WA)

CITATION:   PHARMACY BOARD OF AUSTRALIA and HEGDE [2023] WASAT 109

MEMBER:   JUDGE K GLANCY, DEPUTY PRESIDENT

MR D AITKEN, SENIOR MEMBER

MS E PERRELLA, SESSIONAL MEMBER

HEARD:   18 SEPTEMBER 2023

DELIVERED          :   13 NOVEMBER 2023

FILE NO/S:   VR 96 of 2017

PHARMACY BOARD OF AUSTRALIA

Applicant

AND

CHETAN ANANT HEGDE

Respondent


Catchwords:

Vocational regulation - Pharmacist - Disciplinary proceedings - Professional misconduct - Factors relevant to penalty - Dispensing of anabolic androgenic steroids - Registration suspended for a period of two months

Legislation:

Health Practitioner Regulation National Law (WA) Act 2010 (WA), s 3(2)(a), s 4, s 5, s 6, s 196, s 196(1)(b)(iii), s 196(2), s 196(4)
Legal Profession Act 2008 (WA)

Result:

Practitioner reprimanded
Practitioner's registration suspended for a period of two months
Practitioner fined amount of $10,000

Category:    B

Representation:

Counsel:

Applicant : J McKenzie & E Caddy
Respondent : A P Hershowitz

Solicitors:

Applicant : Minter Ellison
Respondent : Meridian Lawyers (Perth)

Case(s) referred to in decision(s):

Chen v Health Care Complaints Commission (2017) 95 NSWLR 334

Hamilton v Pharmacy Board of Australia [No 2] [2022] WASCA 155

Hegde v Pharmacy Board of Australia [2020] WASC 383

Hegde v Pharmacy Board of Australia [No 2] [2020] WASC 384

Khosa v Legal Professional Complaints Committee [2017] WASCA 192

Legal Profession Complaints Committee v Segler [2014] WASC 159

Medical Board of Australia and Singh [2017] WASAT 33 (S)

Nadkarni v Medical Board of Australia [2022] WASCA 109

Panegyres v Medical Board of Australia [2020] WASCA 58

Pharmacy Board of Australia and Hamilton [2018] WASAT 95

Pharmacy Board of Australia and Nyoni [2018] WASAT 134 (S)

Singh v Medical Board of Australia [2019] WASCA 51

Young v Legal Profession Complaints Committee [2022] WASCA 52

REASONS FOR DECISION OF THE TRIBUNAL:

Introduction

  1. On 7 August 2020, Mr Chetan Hegde (variously the Respondent or Mr Hegde), a pharmacist, was found guilty of professional misconduct as defined in s 5 of the Health Practitioner Regulation National Law (WA) Act 2010 (WA) (National Law) by a differently constituted Tribunal which also imposed a penalty pursuant to s 196(2) of the National Law.[1]

    [1]  Order 1 of the Orders made on 7 August 2020.

  2. That finding of professional misconduct was made after the parties had filed an Agreed Statement of Facts and Findings on 1 July 2019 (Agreed Facts and Findings) that addressed the Respondent's liability for his conduct.[2]

    [2] The Agreed Facts and Findings were Annexure A to orders made on 3 July 2019.

  3. Following an appeal to the Supreme Court,[3] the orders relating to penalty were set aside and an order was made that the question of penalty be remitted for hearing and determination according to law by the Tribunal differently constituted.[4]

    [3] Hegde v Pharmacy Board of Australia [2020] WASC 383 (Hegde Appeal Decision).

    [4] Supreme Court Orders dated 23 October 2020.

  4. This matter concerns the penalty to be…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read PHARMACY BOARD OF AUSTRALIA and HEGDE and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2023] WASAT 109
Decision Date

CaseChat Overview and Summary

The case before the Tribunal concerns the penalty to be imposed on Mr Hegde, a pharmacist, for his professional misconduct, which involved the dispensing of anabolic androgenic steroids in a manner that did not align with recognised therapeutic standards and posed significant health risks. The decision follows an appeal to the Supreme Court, which set aside the original penalty and remitted the question of penalty for hearing and determination by the Tribunal. The Tribunal was tasked with determining an appropriate penalty, considering the serious nature of the misconduct and the unique circumstances of this case.

The legal issues before the Tribunal centred on the appropriate penalty for Mr Hegde's misconduct, which included dispensing anabolic androgenic steroids in quantities and combinations that were not necessary for therapeutic purposes, failing to provide adequate clinical notes, and dispensing repeat authorisations and multiple prescriptions in close proximity. The Tribunal needed to balance the seriousness of the misconduct with the unique circumstances of the case, including the implications of the Court of Appeal's decision in Hamilton v Pharmacy Board of Australia [No 2]. The Tribunal also had to consider the potential adverse effects of anabolic androgenic steroids and the financial incentives for practitioners involved in their inappropriate dispensing.

In reaching its decision, the Tribunal considered the Agreed Facts and Findings, expert reports, witness statements, character references, and submissions from both the Pharmacy Board of Australia and Mr Hegde. The Tribunal noted that while the professional misconduct was serious, the unique circumstances of this case warranted a different approach to penalty. The Tribunal accepted that the potential side effects of anabolic androgenic steroids and the financial rewards for their inappropriate dispensing were critical factors in determining the penalty. The Tribunal also considered the implications of the Court of Appeal's decision in Hamilton, which had implications for the penalty to be imposed in this case. Ultimately, the Tribunal decided that a reprimand, a suspension of Mr Hegde's registration for two months, and a fine of $10,000 were appropriate penalties given the circumstances.

The Tribunal ordered that Mr Hegde be reprimanded, his registration suspended for a period of two months, and that he pay a fine of $10,000. These penalties reflect the seriousness of the professional misconduct while also taking into account the unique circumstances of this case. The Tribunal's decision underscores the importance of considering the full context of each case when determining appropriate penalties for professional misconduct.

Orders

Orders of the court

Background

Background to the litigation

That finding of professional misconduct was made after the parties had filed an Agreed Statement of Facts and Findings on 1 July 2019 (Agreed Facts and Findings) that addressed the Respondent's liability for his conduct.[2][2] The Agreed Facts and Findings were Annexure A to orders made on 3 July 2019. Following an appeal to the Supreme Court,[3] the orders relating to penalty were set aside and an order was made that the question of penalty be remitted for hearing and determination according to law by the Tribunal differently constituted.[4][3] Hegde v Pharmacy Board of Australia [2020] WASC 383 (Hegde Appeal Decision).[4] Supreme Court Orders dated 23 October 2020. This matter concerns the penalty to be imposed in response to Mr Hegde's professional misconduct. Mr Hegde's professional misconduct was that he:(1)engaged in the practice of dispensing anabolic androgenic steroids to patients for the purpose which he ought to have known did not accord with recognised therapeutic standards;(2)engaged in the practice of dispensing anabolic androgenic steroids to patients in quantities and/or in combinations which he ought to have known were not necessary for any proper therapeutic purpose, and were likely to constitute an unacceptable hazard to the health of patients and/or others to whom those drugs could be on-sold, and had the potential for misuse, abuse or psychological and/or physical dependency;(3)engaged in the practice of dispensing anabolic androgenic steroids to patients by dispensing repeat authorisations and/or multiple prescriptions in the same transactions or in separate transactions conducted significantly within the period in which the medication would have been consumed if taken at the usual dose, when he ought to have known those quantities and/or combinations of the drugs supplied was likely to constitute an unacceptable hazard to the health of patients or others to whom those drugs could be on-sold and had the potential for misuse and abuse and/or physical dependency; and(4)failed to make any adequate clinical notes in relation to discussions with patients counselling them in the use of anabolic androgenic steroids and/or the physical condition of the patients to whom he typically dispensed androgenic steroids. For the reasons which follow, we find that although the professional misconduct was serious, in the highly unusual circumstances of this case, to which we refer below, the appropriate penalty to be imposed today is:(1)a reprimand;(2)the suspension of Mr Hegde's registration for a period of two months; and(3)the imposition of a fine of $10,000. In determining the question of penalty, the parties agreed that we would have had regard to the following material:(1)The Agreed Facts and Findings (Exhibit A);(2)The reports of Dr Seubert dated 9 September 2016 (Exhibit B1) and 17 October 2016 (Exhibit B2);(3)Mr Hegde's witness statements dated 12 April 2021 (Exhibit C1) and 30 August 2023 (Exhibit C2)[5];[5] Leave was given on 18 September 2023 for the Respondent to rely on the witness statement as amended by agreement of the parties on 18 September 2023. It was then exhibited as C2.(4)18 character references filed by Mr Hegde (Exhibit D); and(5)A copy of a report from WAtoday dated 9 April 2021 entitled 'Perth pharmacist struck off register over misconduct in dispensing steroids' (Exhibit E).(6)The following documents filed by the Pharmacy Board of Australia (Applicant):(a)Submissions in respect of sanction dated 12 August 2021;(b)Supplementary submissions in respect of penalty dated 23 February 2023; and(c)Proposed conditions to be imposed on Mr Hegde's registration following the expiry of any period of suspension that may be imposed by way of penalty.[6][6] The Applicants filed proposed conditions on 16 November 2021 but refiled them on 18 September 2023 as Applicant's Minute of Proposed Conditions (originally filed on 16 November 2021).(7)The following documents filed by the Respondent:(a)Outline of submissions for penalty hearing on 20 September 2019 dated 19 September 2019;(b)Respondent's submissions concerning proposed conditions dated 22 November 2021;(c)Supplementary submissions in respect of penalty dated 20 March 2023; and(d)Further submissions in respect of penalty dated 30 August 2023; and(e)Further submissions regarding Applicant's proposed conditions refiled 18 September 2023; dated 21 September 2023.(8)The transcript of the hearing on 16 November 2021.

Evidence

Evidence Before The Court

Decision

Reasons for decision

In the Agreed Facts and Findings, the parties agreed on the reasons why people may seek to use anabolic androgenic steroids, on the fact that they can be on-sold by patients who obtain them on prescription and on the potential adverse side effects of anabolic androgenic steroids or excessive or prolonged use of anabolic androgenic steroids.[49] They were also referred to by Quinlan CJ in his Honour's reasons for decision in the Hegde Appeal Decision.[50] Other than to say that the potential side effects are numerous and significant, we do not need to repeat those matters in these reasons.[49] Exhibit A, paras 11 and 12.[50] Hegde Appeal Decision at [14] and [15]. The Applicant submits, and we accept, that it is the serious nature of those risks, combined with the ready market for the drugs and the financial rewards for practitioners who prescribe and dispense them in satisfaction of that demand that is of fundamental importance to the determination of penalty in cases involving a sustained and intensive practice of inappropriately prescribing or dispensing the drugs. It follows from the fact that the prescribing, for which Mr Hegde is to be disciplined, took place over 16 months and involved the dispensing to numerous patients, and the supplying of the anabolic androgenic steroids on many occasions, that Mr Hegde's conduct was serious. The determination of the penalty to be imposed in this case was deferred while the Court of Appeal was considering the decision in Hamilton v Pharmacy Board of Australia [No 2][51] (Hamilton). Following the delivery of the Court of Appeal's decision in that case, the President of the Tribunal made orders permitting the parties to address issues which she had raised about the implication of that decision on the Mr Hegde's case.[51] Hamilton v Pharmacy Board of Australia [No 2] [2022] WASCA 155. Both the Applicant and the Respondent have made comprehensive written and oral submissions about the implications of the decision in Hamilton on the penalty to be imposed in that this case. The Applicant and the Respondent have also filed detailed submissions setting out penalties which have been imposed in other cases and highlighting the similarities and differences between them and Mr Hegde's case. Before considering those cases, it is important to note that the penalty in each case must be determined having regard to the purpose for which it is to be imposed, the circumstances involved in the professional misconduct and the individual circumstances of the practitioner. It is axiomatic that there is no tariff for this kind of behaviour[52] because so much will depend on the whole of the circumstances.[52] Jemielita v The Medical Board of Western Australia [1994] WASC 623 at page 9 (Rowland J). In Hamilton, the Court of Appeal upheld the pharmacist's appeal, set aside the penalty of suspension of her registration for a period of 30 months and, instead, imposed a suspension of the practitioner's registration for a period of 12 months.

Ratio Decidendi

Legal Principle Established